Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1995-06-07
1998-10-06
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
435811, 424435, A61K 3821
Patent
active
058173072
ABSTRACT:
Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The method is particularly suitable for the treatment of antibiotic-resistant infections. IFN-.alpha. is administered in solution or in the form of a saliva-dissolvable lozenge.
REFERENCES:
patent: 3906092 (1975-09-01), Hilleman et al.
patent: 4053582 (1977-10-01), Stickl
patent: 4273703 (1981-06-01), Osther et al.
patent: 4276282 (1981-06-01), Sugimoto et al.
patent: 4460574 (1984-07-01), Yabrov
patent: 4462985 (1984-07-01), Cummins, Jr.
patent: 4465702 (1984-08-01), Eastman et al.
patent: 4496537 (1985-01-01), Kwan
patent: 4497795 (1985-02-01), Cummins
patent: 4507281 (1985-03-01), Asculai et al.
patent: 4605555 (1986-08-01), Sato et al.
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4820515 (1989-04-01), Cummins
patent: 5215741 (1993-06-01), Young et al.
Rodder, H.; Thumann, D.; Thumann, E., Tierarziliche Umschau, 1979, vol. 34, No. 10, pp. 720-724 (summary).
Toneva, V., Bulletin de l'Office International des Epizooties, 1977, vol. 88, pp. 631-637 (summary).
Finter, N.B.; Oldham, R.R., (eds.), In Vivo and Clinical Studies, Interferon, 1985, vol. 4, pp. 137, 148, 173, 218, 226, 284, 285, 330.
Time and Dosage Dependence of Immunoenhancement by Murine Type II Interferon Preparations, Cellular Immunology, 1978, 40, pp. 285-293.
Stewart II, W.E.; Gottlieb, A.A. (eds.), Interferons and Their Actions, 1977, pp. 102-104.
Werenne, J.; Broecke, C.V.; Schwers, A.; Goossens, A.; Buguyaki, L.; et al., Antiviral Effect of Bacterially Produced Human Interferon (Hu-IFNa.sub.2) Against Experimental Vaccinia Infection in Calves, Journal of Interferon Research, 1985, 5:129-136.
Roney, C.S., et al., Effect of Human Leukocyte A Interferon on Prevention of Infectious Bovine Rhinotracheitis Virus Infection of Cattle, Am. J. Vet. Res., Jun. 1985, vol. 46, No. 6, pp. 1251-1255.
Tompkins, M.B.; Cummins, J.M., Response of Feline Leukemia Virus-Induced Nonregenerative Anemia to Oral Administration of an Interferon-Containing Preparation, Feline Practice, May-Jun. 1982, vol. 12, No. 3, pp. 6-15.
Miller, B., Interferon Enters the Fray, Farm Journal, Oct. 1985, pp. 12-13.
Grob, P.J., et al., Interferon as an Adjuvant for Hepatitis B Vaccination in Non-and Low-Responder Populations, Eur. J. Clin. Microbiol., Jun. 1984, vol. 3, No. 3, pp. 195-198.
Cummins, J.M.; Rosenquist, B.D., Protection of Calves Against Rhinovirus Infection by Nasal Secretion Interferon Induced by Infectious Bovine Rhinotracheitis Virus, American Journal of Veterinary Research, Feb. 1980, vol. 41, pp. 161-165.
Loan, R.W. (ed.), Bovine Respiratory Disease--A Symposium, Texas A&M University Press, College Station, TX, 1984, pp. 484-485.
Greenberg, S.B.; Harmon, M.W.; Johnson, P.E., Activity of Exogenous Interferon in the Human Nasal Mucosa, Texas Reports on Biology and Medicine, 1977, vol. 35, pp. 491-496.
Merigan, T.C.; Hall, T.S.; Reed, S.E.; Tyrell, D.A., Inhibition of Respiratory Virus Infection by Locally Applied Interferon, The Lancet, Mar. 17, 1973, pp. 563-567.
Tyrrell, D.A.J., Trials of Interferon in Respiratory Infections of Man, Texas Reports on Biology and Medicine, 1977, vol. 35, pp. 486-490.
Shalaby, M.R.; Weck, P.K., Bacteria-Derived Human Leukocyte Interferons After in Vitro Humoral and Cellular Immune Responses, 82, 1983, pp. 269-281.
Strander, H.; Cantrell, K.; Carlstron, G.; Jakobsson, P.A., Clinical and Laboratory Investigations on Man: Systemic Administration of Potent Interferon to Man, J. Natl. Cancer Inst., 1973, 51: 733-742.
Vlatkovic, R., et al., Application of Human Leukocyte Interferon in Severe Cases of Virus B Hepatitis, Proc. Symposium on Interferon, 1979, Yugoslav Academy of Sciences and Arts, Zagreb, pp. 173-183.
Effect of Interferon on Vaccination in Volunteers, The Lancet, Apr. 28, 1962, pp. 873-875 (report to Medical Research Council from the Scientific Committee on Interferon).
Oh, J.O.; Yoneda, C., Induction of Ocular Resistance to Vaccinia Virus by Typhoid Vaccine; Role of Interferon, The Journal of Immunology, 1969, vol. 102, No. 1, pp. 145-154.
Clinical Trails With Exogenous Interferon; Summary of a Meeting, The Journal of Infectious Diseases, Jan. 1979, vol. 139, No. 1, pp. 109-123.
Soloviev, V.D., Geo. Rita (ed.), Some Results and Prospects in the Study of Endogenous and Exogenous Interferon, The Interferson, An International Symposium, Academic Press, 1968, pp. 233-243.
Influenza and Interferon Research in the Soviet Union--Jan. 1973, The Journal of Infectious Disease, Aug. 1973, vol. 128, No. 2, pp. 261-264.
Solov'ev, V.D., The Results of Controlled Observations on the Prophlaxis of Infuenza with Interferon World Health Organization, 1949, 41, 683-688.
Jia-xiong, D., et al., Children's Respiratory Viral Diseases Treated with Interferon Aerosol Chinese Medical Journal, 1987, 100 (2): 162-166.
Sommerville, R.G., Essential Clinical Virology, Blackwell Scientific Publications, pp. 154-157.
Davies, H.W. et al, Comparative Intranasal Pharmacokinetics of Interferon Using Two Spray Systems, J. Interferon Research, 1983, pp. 443-449.
Couch, R.B., The Common Cold Control? The Journal of Infectitious Diseases, Aug. 1984, vol. 150, No. 2, pp. 167-173.
Mandell, G.L.; Douglas, Jr., R.G.; Bennett, J.E. (eds.), Principles and Practice of Infectious Diseases, 2nd ed., A Wiley Medical publication, pp. 85-96, 863, 968.
Galasso, G.J.; T.C., Merigan; Buchanan, R.A., Antiviral Agents and Viral Diseases of Man, Raven Press, New York, 1979, pp. 407-408, 430-431.
Galasso, G.J.; T.C. Merigan; Buchanan, R.A., Antiviral Agents and Viral Diseases of Man, Raven Press, new York, 1984, pp. 145-178, 344-345.
Interferon Perspective, Information on interferon provided in 1981 by the International Preventative Medicine Foundation, Melbourne, FL, Ronald Jones, Vice President.
American Interhealth, Melbourne Beach, FL, Production Information.
Biovet International, Inc., Canine and Feline Interferons, 1981 Product Description and label.
Agriferon.RTM.-C, Immuno Modulators Laboratories, Inc., Stafford, TX, Lymphokine Preparation for Prophylactic Treatment of Infectious Bovine Rhinotracheitis Virus Associated With Shipping Fever-for cattle use in Texas only, product brochure.
Agriferon.RTM.-C, A Bold New Approach To Managing Shipping Fever In Cattle Immuno Modulator Laboratories, Inc., Stafford, TX, product advertisement.
Equiferon, A Totally New Approach To Viral Respiratory Infection In Horses Immuno Modulator Laboratories, Inc., Stafford, TX, product advertisement.
Pet Interferon Alpha, Lymphokine Preparation For Treatment of Feline Leukemia Virus and Canine Parvovirus Diseases, Amarillo Cell Culture Co., Inc., Amarillo, TX, product brochure.
Texas Department of Health Application for License for Human Interferon Alpha (Alpha Interferon) as Pet Interferon, Amarillo Cell Culture Company, Inc., May 6, 1985.
Cantel, K.; Ryhala, L., Circulating Interferon in Rabbits After Administration of Huiman Interferon by Different Routes, Journal of General Virology, 1973, 20:97-104.
Wills, R.J,; Spiegel, H.E.; Soikel, K.F., Pharmacokinetics of Recombinant Alpha A Interferon Following IV Infusion and Bolus, IM and PO Administrations to African Green Monkeys, Journal of Interferon Research, 1984, vol. 4, No. 3, pp. 399-409.
Gibson, D.M., et al., Pharmacokinetics of Recombinant Leukocyte A Interferon Following Various Routes and Modes of Adminstration To The Dog, Journal of Interferon Research, 1985, 5:403-408.
Smerdel, S., et al., Stimulation of Humoral Immunity by Interferon, III Mediterranean Congress of Chemotherapy, Sep. 21-24, 1982 presentation, vol. 2, p. 132, Oct. 1983.
Braun, W.; Levy, H.B., Interferon Preparations as Modifiers of Immune Responses, Proc. Soc. Exp. Biol. Med., 1972, vol. 141, pp. 769-773.
DeMaeyer, E., Interferon and the Immune System: A Review (Limited to Alpha and Beta Interferons), The Biology of the Interferon System, Elsevier/North-Holland Biomedical Press, 1981, pp. 203-209.
Vignauz, F., et al
Fitzgerald David L.
The Texas A&M University System
LandOfFree
Treatment of bacterial infection with oral interferon-.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of bacterial infection with oral interferon-.alpha., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of bacterial infection with oral interferon-.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-74416